Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City

College of Physicians and Surgeons, Center for Family and Community Medicine, Columbia University, New York, NY 10032, USA.
Journal of Community Health (Impact Factor: 1.28). 06/2008; 33(3):139-48. DOI: 10.1007/s10900-007-9082-4
Source: PubMed


Hepatitis B (HBV) vaccination coverage remains low among drug users. In 1997, ACIP made hepatitis B vaccine available for persons aged 0-18 years and many states began requiring HBV vaccination for entry into middle school; these programs might affect HBV vaccination and infection rates in younger DUs. We were interested in determining correlates of immunization among younger (<25 years) and older (25 and older) DUs.
A community-based sample of 1,211 heroin, crack, and cocaine users 18 or older was recruited from Harlem and the Bronx. We assessed previous HBV vaccination and infection and correlates using bivariate analyses.
The sample was predominantly male (74.0%), aged > or =25 years (67.1%) and Hispanic (59.9%). In terms of socioeconomic status, 57.1% had less than a high school education, 84.5% had been homeless in their lifetime, and 48.0% had an illegal main income source. Among 399 DUs younger than 25 years of age, 30% demonstrated serological evidence of previous vaccination, 49.9% were susceptible to HBV at baseline, and 20% showed evidence of infection. In our model, previous HBV infection and vaccination status were associated with being 22 years old or younger (AOR = 1.40 and 1.66). Compared to susceptible individuals, those vaccinated were significantly less likely to be born in other countries (AOR = 0.50). Among 812 DUs 25 and older, 10.6% demonstrated serological evidence of previous vaccination, 59.2% were susceptible to HBV at baseline, and 30.2% showed evidence of infection.
Existing interventions to increase HBV vaccination among adolescents should target high risk groups.

Download full-text


Available from: Danielle C Ompad, Feb 26, 2014
  • Source
    • "The correlates of HBV infection were: older age, being unemployed, injecting use, and HIV infection (Table I). The correlation with being unemployed supports the role of socioeconomic disadvantages [15], although no correlation with educational level was found. The correlation with injecting use (70.4% prevalence among the 449 IDUs tested) confirms the role of parenteral transmission. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug users in Italy continue to have a high prevalence of infection with the human immunodeficiency virus and hepatitis B and C viruses, associated with older age, being unemployed, injecting use, and a longer history of injecting. The results underline the need for control programmes among drug users in Italy.
    Scandinavian Journal of Infectious Diseases 06/2009; 41(6-7):520-3. DOI:10.1080/00365540902946528 · 1.50 Impact Factor
  • Source

    Journal of Urban Health 11/2008; 86(2):157-60. DOI:10.1007/s11524-008-9327-2 · 1.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Non-injecting drug users are at high-risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non-injecting drug users in the Central-West region of Brazil. HBV genotypes and predictors of infection were also identified. A total of 852 individuals in 34 drug treatment centers were interviewed, and their serum samples were tested for the presence of HBV markers by ELISA. HBsAg and anti-HBc-positive samples were tested for HBV DNA by PCR. Samples with HBV DNA were genotyped by restriction fragment length polymorphism (RFLP). The overall prevalence of HBV infection was 14% (95% CI: 11.7-16.5). A multivariate analysis of risk factors showed that age >30 years, non-white race/ethnicity, duration of drug use >10 years, lifetime number of sexual partners >10, non-use of condoms, and HCV and HIV status were associated significantly with HBV infection. Of the 9 (1%) HBsAg-reactive samples, HBV DNA was present in 2/2 of HBeAg-positive and in 5/7 anti-HBe-positive samples. An occult HBV infection rate of 2.7% (3/110) was found among anti-HBc-positive individuals. All HBV DNA-positive samples were genotyped: seven were genotype A, two were genotype D, and one was genotype F. Finally, few individuals (8%) had serological evidence of a previous HBV vaccination. These findings indicate that preventive interventions are needed for both sexual and drug-related high-risk behavior. Additionally, non-injecting drug users should be targeted for HBV vaccination.
    Journal of Medical Virology 04/2009; 81(4):602-9. DOI:10.1002/jmv.21464 · 2.35 Impact Factor
Show more